Obligation General Electric Co. 3.45% ( US369604BV43 ) en USD

General Electric Co.

100 % ▲

Etats-unis

US369604BV43 ( en USD )

3.45% par an ( paiement semestriel )

30/04/2027

Prospectus brochure de l'obligation General Electric US369604BV43 en USD 3.45%, échéance 30/04/2027

2 000 USD

1 000 000 000 USD

369604BV4

BBB+ ( Qualité moyenne inférieure )

Baa1 ( Qualité moyenne inférieure )

01/11/2025 ( Dans 90 jours )

General Electric est une société multinationale américaine opérant dans divers secteurs industriels, notamment l'énergie, l'aviation, les soins de santé et les technologies financières.

Une analyse détaillée de l'obligation émise par General Electric, identifiée par son code ISIN US369604BV43 et son code CUSIP 369604BV4, révèle ses caractéristiques financières clés. General Electric (GE), un conglomérat industriel diversifié mondial historiquement impliqué dans l'aviation, la santé et les énergies renouvelables et actuellement en pleine restructuration, est l'émetteur de ce titre de créance libellé en USD. Avec un taux d'intérêt annuel de 3,45% versé semi-annuellement, cette obligation américaine, dont la maturité est fixée au 30 avril 2027, fait partie d'une émission totale de 1 000 000 000 USD et est accessible à l'achat à partir d'un montant minimal de 2 000 USD. Actuellement négociée à 100% de son prix nominal sur le marché, la qualité de crédit de cette émission est attestée par les agences de notation : elle bénéficie d'une notation BBB+ par Standard & Poor's et Baa1 par Moody's, reflétant sa classification dans la catégorie d'investissement.

3B2 EDGAR HTML -- c95731_preflight.htm
424B2 1 c95731_424b2.htm
File d Pursua nt t o Rule 4 2 4 (b)(2 )
Re gist ra t ion N o. 3 3 3 -2 2 9 8 8 6
CALCU LAT I ON OF REGI ST RAT I ON FEE

Propose d
Am ount
M a x im um
M a x im um
Am ount of
T it le of Ea c h Cla ss of
t o be
Offe ring Pric e
Aggre ga t e
Re gist ra t ion
Se c urit ie s t o be Re gist e re d
Re gist e re d
Pe r U nit
Offe ring Pric e
Fe e (1 )
3.450% Notes due 2027
$1,000,000,000
99.845%
$998,450,000
$129,598.81
3.625% Notes due 2030
$1,250,000,000
99.841%
$1,248,012,500
$161,992.02
4.250% Notes due 2040
$1,500,000,000
99.718%
$1,495,770,000
$194,150.95
4.350% Notes due 2050
$2,250,000,000
99.650%
$2,242,125,000
$291,027.83
(1)
Calculated in accordance with Rule 457(r) of the Securities Act. A filing fee of $776,769.60 is being paid in connection with
this offering.

PROSPECTUS SUPPLEMENT
(To Prospectus dated February 26, 2019)
General Electric Company
$1,000,000,000 3.450% Notes due 2027
$1,250,000,000 3.625% Notes due 2030
$1,500,000,000 4.250% Notes due 2040
$2,250,000,000 4.350% Notes due 2050
We are offering $1,000,000,000 of 3.450% Notes due 2027 (the "2027 Notes"), $1,250,000,000 of 3.625% Notes due 2030 (the "2030
Notes"), $1,500,000,000 of 4.250% Notes due 2040 (the "2040 Notes") and $2,250,000,000 of 4.350% Notes due 2050 (the "2050 Notes"). The
2027 Notes, the 2030 Notes, the 2040 Notes and the 2050 Notes are collectively referred to herein as the "notes."
We will pay interest on the notes semi-annually on May 1 and November 1 of each year beginning on November 1, 2020. The 2027 Notes will
bear interest at the rate of 3.450% per annum. The 2030 Notes will bear interest at the rate of 3.625% per annum. The 2040 Notes will bear interest
at the rate of 4.250% per annum. The 2050 Notes will bear interest at the rate of 4.350% per annum. The 2027 Notes will mature on May 1, 2027.
The 2030 Notes will mature on May 1, 2030. The 2040 Notes will mature on May 1, 2040. The 2050 Notes will mature on May 1, 2050.
We may redeem the notes of each series at any time and from time to time prior to March 1, 2027 (in the case of the 2027 Notes), February 1,
2030 (in the case of the 2030 Notes), November 1, 2039 (in the case of the 2040 Notes) and November 1, 2049 (in the case of the 2050 Notes) as a
whole or in part, at our option, at the applicable redemption prices described in this prospectus supplement. We may redeem all or a portion of the
notes of each series at our option at any time and from time to time on or after March 1, 2027 (in the case of the 2027 Notes), February 1, 2030 (in
the case of the 2030 Notes), November 1, 2039 (in the case of the 2040 Notes) and November 1, 2049 (in the case of the 2050 Notes), at a
redemption price equal to 100% of the principal amount of such notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding,
the redemption date.
The notes will be unsecured obligations and rank equally with our other unsecured and unsubordinated indebtedness. The notes will be issued
only in fully registered, book-entry form in denominations of $2,000 and integral multiples of $1,000 in excess thereof.
https://www.sec.gov/Archives/edgar/data/40545/000093041320001094/c95731_424b2.htm[4/15/2020 8:30:02 AM]

3B2 EDGAR HTML -- c95731_preflight.htm
See "Risk Factors" on page S-9 for a discussion of certain risks that should be considered in connection with an investment in the
notes.

Price to
Underwriting
Proceeds, Before
Public(1)
Discount
Expenses, to us(1)

Per 2027 Note

99.845%

0.410%

99.435%

2027 Notes total
$ 998,450,000
$ 4,100,000
$
994,350,000

Per 2030 Note

99.841%

0.450%

99.391%

2030 Notes total
$ 1,248,012,500
$ 5,625,000
$ 1,242,387,500

Per 2040 Note

99.718%

0.750%

98.968%

2040 Notes total
$ 1,495,770,000
$ 11,250,000
$ 1,484,520,000

Per 2050 Note

99.650%

0.875%

98.775%

2050 Notes total
$ 2,242,125,000
$ 19,687,500
$ 2,222,437,500

Total
$ 5,984,357,500
$ 40,662,500
$ 5,943,695,000

(1) Plus accrued interest from April 22, 2020, if settlement occurs after that date.
We do not intend to apply to list the notes on any securities exchange.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of the notes or
determined that this prospectus supplement or the accompanying prospectus is accurate or complete. Any representation to the contrary
is a criminal offense.
The underwriters expect to deliver the notes in book-entry form only through the facilities of The Depository Trust Company, for the benefit
of its participants, including Euroclear Bank S.A./N.V. and Clearstream Banking, société anonyme, on or about April 22, 2020.
Bookrunners

BofA Securities

J.P. Morgan

Morgan Stanley
BNP PARIBAS

Credit Suisse

Deutsche Bank Securities
Senior Co-Managers

HSBC

Mizuho Securities

MUFG

SMBC Nikko
Co-Managers

Blaylock Van, LLC

Mischler Financial Group, Inc.

R. Seelaus & Co., LLC
The date of this prospectus supplement is April 13, 2020.

ABOUT THIS PROSPECTUS SUPPLEMENT
This document is in two parts. The first part is this prospectus supplement, which describes the terms of the offering of the notes.
The second part is the accompanying prospectus dated February 26, 2019, which we refer to as the "accompanying prospectus." The
accompanying prospectus contains a description of our debt securities and gives more general information, some of which may not
apply to the notes. If the information set forth in this prospectus supplement differs in any way from the information set forth in the
accompanying prospectus, you should rely on the information set forth in this prospectus supplement.
We are responsible for the information contained in or incorporated by reference in this prospectus supplement, the
accompanying prospectus and in any related free writing prospectus we prepare or authorize. We have not, and the underwriters have
not, authorized anyone to give you any other information, and neither we nor the underwriters take responsibility for any other
information that others may give you. We are not, and the underwriters are not, making an offer of these securities in any jurisdiction
where the offer or sale is not permitted. You should not assume that the information provided by this prospectus supplement, the
accompanying prospectus or the documents incorporated by reference in this prospectus supplement and in the accompanying
prospectus is accurate as of any date other than their respective dates. Our business, financial condition, results of operations and
prospects may have changed since those dates.
Before you invest in the notes, you should carefully read the registration statement described in the accompanying prospectus
(including the exhibits thereto) of which this prospectus supplement and the accompanying prospectus form a part, this prospectus
supplement, the accompanying prospectus and the documents incorporated by reference into this prospectus supplement and the
https://www.sec.gov/Archives/edgar/data/40545/000093041320001094/c95731_424b2.htm[4/15/2020 8:30:02 AM]

3B2 EDGAR HTML -- c95731_preflight.htm
accompanying prospectus. The incorporated documents are described in this prospectus supplement under "Where You Can Find
More Information."
Except as the context may otherwise require in this prospectus supplement, references to "General Electric" refer to General
Electric Company and to "GE," "we," "us" and "our" refer to General Electric Company and its subsidiaries. In addition, references
to "GE Capital" and "Capital" refer to GE Capital Global Holdings, LLC and its subsidiaries.
S-i

TABLE OF CONTENTS

Page

Prospectus Supplement
Where You Can Find More Information
S-1

Forward-Looking Statements
S-2

Summary of the Offering
S-4

Risk Factors
S-9

S-
Use of Proceeds
11

S-
Description of Notes
12

S-
Certain United States Federal Income And Estate Tax Considerations
19

S-
Underwriting
23

S-
Validity of the Notes
29

S-
Experts
29

Prospectus
About This Prospectus

1

Where You Can Find More Information

1

Forward-Looking Statements

2

The Company

4

Risk Factors

4

Use of Proceeds

4

General Description of Securities

5

Description of Debt Securities

5

Description of Preferred Stock
19

Description of Common Stock
19

Description of Warrants
19

Description of Delayed Delivery Contracts
20

Description of Guarantees
20

Plan of Distribution
21

Validity of the Securities
24

Experts
24

S-ii

WHERE YOU CAN FIND MORE INFORMATION
We file annual, quarterly and current reports, proxy statements and other information with the Securities and Exchange
Commission (the "SEC"). Our SEC filings are available to the public from the SEC's web site at http://www.sec.gov. Information
about us, including our SEC filings, is also available at our Internet site at http://www.ge.com. However, the information on our
Internet site is not a part of this prospectus supplement or the accompanying prospectus.
https://www.sec.gov/Archives/edgar/data/40545/000093041320001094/c95731_424b2.htm[4/15/2020 8:30:02 AM]

3B2 EDGAR HTML -- c95731_preflight.htm
The SEC allows us to "incorporate by reference" in this prospectus supplement and the accompanying prospectus the information
in other documents that we file with it, which means that we can disclose important information to you by referring you to those
documents. The information incorporated by reference is considered to be a part of this prospectus supplement and the accompanying
prospectus, and information in documents that we file later with the SEC will automatically update and supersede information
contained in documents filed earlier with the SEC or contained in this prospectus supplement and the accompanying prospectus. We
incorporate by reference in this prospectus supplement and the accompanying prospectus the documents listed below and any future
filings that we may make with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934, as amended
(the "Exchange Act"), until we sell all of the securities that may be offered by this prospectus supplement; provided, however, that we
are not incorporating, in each case, any documents or information deemed to have been furnished and not filed in accordance with
SEC rules:

· the Annual Report on Form 10-K for the year ended December 31, 2019 that we filed with the SEC on February 24, 2020;

· the Current Reports on Form 8-K that we filed with the SEC on February 20, 2020, April 6, 2020, April 13, 2020 (expressly
excluding the information furnished under Item 2.02) and April 13, 2020; and

· the portions of the Definitive Proxy Statement on Schedule 14A filed on March 12, 2020 for our 2020 annual meeting of
shareowners called for May 5, 2020 incorporated by reference in the Annual Report on Form 10-K for the year ended
December 31, 2019.
You may request a copy of any or all of the documents referred to above which may have been or may be incorporated by
reference into this prospectus supplement and accompanying prospectus (excluding certain exhibits to the documents) at no cost to
you by writing or telephoning us at the following address:
General Electric Company
5 Necco Street
Boston, Massachusetts 02210
Attn: Corporate Investor Communications
(617) 443-3000
S-1

FORWARD-LOOKING STATEMENTS
This prospectus supplement and the information incorporated by reference in this prospectus supplement contain "forward-
looking statements"--that is, statements related to future, not past, events. In this context, forward-looking statements often address
our expected future business and financial performance and financial condition, and often contain words such as "expect,"
"anticipate," "intend," "plan," "believe," "seek," "see," "will," "would," "estimate," "forecast," "target," "preliminary," or "range."
Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about the
potential impacts of the COVID-19 pandemic on our business operations, financial results and financial position and on the world
economy; our expected financial performance, including cash flows, revenues, organic growth, margins, earnings and earnings per
share; macroeconomic and market conditions and volatility; planned and potential business or asset dispositions; our de-leveraging
plans, including leverage ratios and targets, the timing and nature of actions to reduce indebtedness and our credit ratings and
outlooks; GE's and GE Capital's funding and liquidity; our businesses' cost structures and plans to reduce costs; restructuring,
goodwill impairment or other financial charges; planned and potential business or asset dispositions; or tax rates.
For us, particular uncertainties that could cause our actual results to be materially different than those expressed in our forward-
looking statements include:

· the severity, magnitude and duration of the COVID-19 pandemic, including impacts of the pandemic and of businesses' and
governments' responses to the pandemic on our operations and personnel, and on commercial activity and demand across our
and our customers' and suppliers' businesses, and on global supply chains;

· our inability to predict the extent to which the COVID-19 pandemic and related impacts will continue to adversely impact our
business operations, financial performance, results of operations, financial position, the prices of our securities and the
achievement of our strategic objectives;

· changes in macroeconomic and market conditions and market volatility (including developments and volatility arising from the
COVID-19 pandemic), including interest rates, the value of securities and other financial assets (including our equity ownership
position in Baker Hughes), oil and other commodity prices and exchange rates, and the impact of such changes and volatility
on our financial position;

https://www.sec.gov/Archives/edgar/data/40545/000093041320001094/c95731_424b2.htm[4/15/2020 8:30:02 AM]

3B2 EDGAR HTML -- c95731_preflight.htm
· our de-leveraging and capital allocation plans, including with respect to actions to reduce our indebtedness, the timing and
amount of GE dividends, organic investments, and other priorities;

· further downgrades of our current short- and long-term credit ratings or ratings outlooks, or changes in rating application or
methodology, and the related impact on our liquidity, funding profile, costs and competitive position;

· GE's liquidity and the amount and timing of our GE Industrial cash flows and earnings, which may be impacted by customer,
supplier, competitive, contractual and other dynamics and conditions;

· GE Capital's capital and liquidity needs, including in connection with GE Capital's run-off insurance operations and
discontinued operations; the amount and timing of required capital contributions to the insurance operations and any strategic
actions that we may pursue; the impact of conditions in the financial and credit markets on GE Capital's ability to sell financial
assets; the availability and cost of funding; and GE Capital's exposure to particular counterparties and markets;

· our success in executing and completing asset dispositions or other transactions, including our plan to exit our equity ownership
position in Baker Hughes, the timing of closing for such transactions and the expected proceeds and benefits to GE;
S-2

· global economic trends, competition and geopolitical risks, including changes in the rates of investment or economic growth in
key markets we serve, or an escalation of trade tensions such as those between the U.S. and China;

· market developments or customer actions that may affect levels of demand and the financial performance of the major
industries and customers we serve, such as secular, cyclical and competitive pressures in our Power business, pricing and other
pressures in the renewable energy market, levels of demand for air travel and other customer dynamics such as early aircraft
retirements, conditions in key geographic markets and other shifts in the competitive landscape for our products and services;

· operational execution by our businesses, including our ability to improve the operations and execution of our Power and
Renewable Energy businesses, and the performance of our Aviation business;

· changes in law, regulation or policy that may affect our businesses, such as trade policy and tariffs, regulation related to climate
change and the effects of U.S. tax reform and other tax law changes;

· our decisions about investments in new products, services and platforms, and our ability to launch new products in a cost-
effective manner;

· our ability to increase margins through implementation of operational changes, restructuring and other cost reduction measures;

· the impact of regulation and regulatory, investigative and legal proceedings and legal compliance risks, including the impact of
Alstom, SEC and other investigative and legal proceedings;

· the impact of actual or potential failures of our products or third-party products with which our products are integrated, such as
the fleet grounding of the Boeing 737 MAX and the timing of its return to service and return to delivery, and related
reputational effects;

· the impact of potential information technology, cybersecurity or data security breaches; and

· the other factors that are described in "Risk Factors" in this prospectus supplement and in our Annual Report on Form 10-K for
the year ended December 31, 2019, as such descriptions may be updated or amended in any future reports we file with the
SEC.
These or other uncertainties may cause our actual future results to be materially different than those expressed in our forward-
looking statements. Forward-looking statements speak only as of the date they were made, and we do not undertake to update them.
S-3

SUMMARY OF THE OFFERING
The following is a brief summary of some of the terms of this offering. It does not contain all of the information that you
need to consider in making your investment decision. To understand all of the terms of the offering of the notes, you should
carefully read this prospectus supplement, the accompanying prospectus and the documents incorporated by reference herein and
therein.
https://www.sec.gov/Archives/edgar/data/40545/000093041320001094/c95731_424b2.htm[4/15/2020 8:30:02 AM]

3B2 EDGAR HTML -- c95731_preflight.htm
About General Electric Company
We are a high-tech industrial company that operates worldwide through our four industrial segments, Power, Renewable
Energy, Aviation and Healthcare, and our financial services segment, Capital. The Power segment offers technologies, solutions,
and services related to energy production, including gas and steam turbines, generators, and power generation services. The
Renewable Energy segment provides wind turbine platforms, hardware and software, offshore wind turbines, solutions, products
and services to the hydropower industry, blades for onshore and offshore wind turbines, and high voltage equipment. The
Aviation segment provides jet engines and turboprops for commercial and military airframes, maintenance, component repair,
and overhaul services, as well as replacement parts, additive machines and materials, and engineering services. The Healthcare
segment provides healthcare technologies in medical imaging, digital solutions, patient monitoring and diagnostics, drug
discovery, biopharmaceutical manufacturing technologies and performance enhancement solutions. The Capital segment leases
and finances aircraft, aircraft engines and helicopters, provides financial and underwriting solutions, and manages our run-off
insurance operations.
We serve customers in over 170 countries. Manufacturing and service operations are carried out at 94 manufacturing plants
located in 30 states in the United States and Puerto Rico and at 190 manufacturing plants located in 37 other countries.
At year-end 2019, General Electric Company and consolidated affiliates employed approximately 205,000 people, of whom
approximately 70,000 were employed in the United States. Our Power, Renewable Energy, Aviation, Healthcare, and Capital
segments employed approximately 38,000, 43,000, 52,000, 56,000 and 2,000 people, respectively. Our Corporate business
employed approximately 13,000 employees.
General Electric's address is 1 River Road, Schenectady, NY 12345-6999. We also maintain executive offices at 5 Necco
Street, Boston, MA 02210. General Electric is incorporated in New York State.
Recent Developments
The global COVID-19 pandemic is having a material adverse impact on our operations, financial performance and prices of
our securities, as well as on the operations and financial performance of many of the customers and suppliers in industries that
we serve. Due to the evolving nature of the COVID-19 pandemic, on April 9, 2020, we withdrew our previously announced
guidance for 2020. Additionally for the first quarter ended March 31, 2020, we indicated that we preliminarily expect our
adjusted EPS to be materially below the prior guidance of about $0.10, and our free cash flow to be near the prior guidance of
about negative $2 billion.
As of March 31, 2020, we held cash, cash equivalents and restricted cash of approximately $47 billion, including
approximately $20 billion in net proceeds from closing the sale of Biopharma to Danaher Corporation ("Danaher"). This included
approximately $34 billion in our Industrial segment and approximately $13 billion in our Capital segment.
We also have access to liquidity from committed and available syndicated credit facilities under our existing $20 billion
revolving syndicated credit facility that matures in May 2021 (the "back-up revolving credit facility") and our existing $14.8
billion revolving syndicated credit facility that matures in December 2020 (the "2018 revolving credit facility"). The aggregate
revolving commitments under the back-up revolving credit facility and 2018 revolving credit facility may be reduced by up to
$6.7 billion due to offset provisions for any bank that holds a commitment to lend under both facilities. We also have various
existing bilateral revolving credit facilities with an
S-4

aggregate revolving commitment of $7.2 billion as of March 31, 2020 and different maturity dates. As of March 31, 2020 we
have access to these facilities in the amount of approximately $35 billion in total. The aggregate revolving commitment for our
2018 revolving credit facility will reduce to $4 billion by its terms on April 14, 2020 due to the closing of the Biopharma
transaction. The 2018 revolving credit facility will terminate upon the closing of the refinancing of our back-up revolving credit
facility, as described below.
As part of our normal financial management process, we are in the process of pursuing a refinancing of our back-up
revolving credit facility. In connection with the refinancing, we intend to terminate the back-up revolving credit facility and
execute a new back-up revolving credit facility with approximately $15 billion in aggregate commitments and a final maturity
date of April 2023 (the "refinanced back-up revolving credit facility"). We anticipate that the refinanced back-up revolving credit
facility will include a customary net debt-to-EBITDA financial covenant. This refinancing transaction is currently in syndication
and the terms of the refinanced back-up revolving credit facility have not been finalized.
https://www.sec.gov/Archives/edgar/data/40545/000093041320001094/c95731_424b2.htm[4/15/2020 8:30:02 AM]

3B2 EDGAR HTML -- c95731_preflight.htm
Year to date 2020, we have taken a number of actions to manage our outstanding debt, including the repayment of
approximately $6 billion of intercompany loans and the repayment of approximately $1.1 billion of our outstanding commercial
paper. In addition, GE Capital paid approximately $4.7 billion of its debt at maturity. Further, we intend to use the net proceeds
of this offering to fund the GE Tender Offers. See "--Tender Offers" and "Use of Proceeds."
We intend to continue to decrease our leverage over time as we navigate this period of uncertainty, although we now expect
to achieve our prior targets over a longer period than previously announced.
See "Risk Factors--The global COVID-19 pandemic is having a material adverse impact on our operations and financial
performance, as well as on the operations and financial performance of many of the customers and suppliers in industries that we
serve. We are unable to predict the extent to which the pandemic and related impacts will continue to adversely impact our
business operations, financial performance, results of operations, financial position and the achievement of our strategic
objectives" for more information.
Tender Offers
Concurrently with this offering, we commenced an offer to purchase for cash any and all of the outstanding 2.700% Notes
due 2022, 0.375% Notes due 2022, 1.250% Notes due 2023, 3.375% Notes due 2024 and Floating Rate Notes due 2020 issued
by General Electric (collectively, the "GE Tender Offers") and any and all of the outstanding 2.250% Notes due 2020, 4.375%
Notes due 2020, 5.875% Notes due 2020 and 2.342% Notes due 2020 issued by subsidiaries of or predecessors to GE Capital
(collectively, the "GE Capital Tender Offers," and, together with the GE Tender Offers, the "Tender Offers"). As of the date of
this prospectus supplement, there were approximately $7.7 billion aggregate principal amount of notes outstanding subject to the
GE Tender Offers and approximately $9.1 billion aggregate principal amount of notes outstanding subject to the GE Capital
Tender Offers.
We intend to fund the GE Tender Offers using the proceeds of this offering. The GE Capital Tender Offers will be funded
using the proceeds of the sale of BioPharma to Danaher, a portion of which were used by General Electric on April 1, 2020 to
repay approximately $6 billion of intercompany loans to GE Capital.
The Tender Offers are made upon the terms and subject to the conditions set forth in the Offers to Purchase, dated April 13,
2020 (as may be amended or supplemented from time to time, the "Offer to Purchase"), and the accompanying notice of
guaranteed delivery (together with the Offer to Purchase, the "Tender Offer Documents"). The Tender Offers will expire at 5:00
p.m. (Eastern time) on April 20, 2020. Holders who validly tender, and who do not validly withdraw their tendered notes, prior
to the expiration of the Tender Offers and deliver the documentation detailed in the Tender Offer Documents by the applicable
dates, and whose notes are accepted by us will
S-5

receive total consideration for their tendered notes in the amount set out in the Tender Offer Documents. The Tender Offers are
expected to settle on April 23, 2020.
The Tender Offers are conditioned upon the satisfaction or waiver of certain conditions as set forth in the Tender Offer
Documents, and, in the case of the GE Tender Offers only, the purchase of notes of a series is conditioned upon sufficient
proceeds from the issuance of the notes offered hereby to fund the total consideration for such series. Consummation of the GE
Capital Tender Offers is not conditioned on the issuance of the notes in this offering. We reserve the right to amend, extend,
withdraw or terminate any of the Tender Offers in our sole discretion. There can be no assurance that the Tender Offers will be
consummated in accordance with the terms described in the Tender Offer Documents, or at all, or that a significant principal
amount of the subject notes will be tendered.
This offering is not conditioned upon completion of any of the Tender Offers. Nothing contained in this prospectus
supplement should be construed as an offer to purchase any of the notes subject to the Tender Offers, as the Tender Offers are
being made only to the recipients of the Tender Offer Documents, upon the terms and subject to the conditions set forth therein.
S-6

The Offering

https://www.sec.gov/Archives/edgar/data/40545/000093041320001094/c95731_424b2.htm[4/15/2020 8:30:02 AM]

3B2 EDGAR HTML -- c95731_preflight.htm
The issuer
General Electric Company, a New York corporation.
Securities offered
$1,000,000,000 3.450% Notes due 2027.

$1,250,000,000 3.625% Notes due 2030.

$1,500,000,000 4.250% Notes due 2040.

$2,225,000,000 4.350% Notes due 2050.
Original issue date
April 13, 2020.
Maturity date
The 2027 Notes will mature on May 1, 2027.

The 2030 Notes will mature on May 1, 2030.

The 2040 Notes will mature on May 1, 2040.

The 2050 Notes will mature on May 1, 2050.
Interest payment dates
Interest on the notes will be paid semi-annually on May 1 and November
1 of each year, beginning on November 1, 2020.
Interest rate
3.450% per annum, for the 2027 Notes.

3.625% per annum, for the 2030 Notes.

4.250% per annum, for the 2040 Notes.

4.350% per annum, for the 2050 Notes.
Redemption
We may redeem the notes of each series at any time and from time to time
prior to March 1, 2027 (in the case of the 2027 Notes), February 1, 2030
(in the case of the 2030 Notes), November 1, 2039 (in the case of the
2040 Notes) and November 1, 2049 (in the case of the 2050 Notes), as a
whole or in part, at our option, at the applicable redemption prices
described under the heading "Description of Notes--Optional Redemption"
in this prospectus supplement.

Notwithstanding the immediately preceding paragraph, we may redeem all
or a portion of the notes of each series at our option at any time and from
time to time on or after March 1, 2027 (in the case of the 2027 Notes),
February 1, 2030 (in the case of the 2030 Notes), November 1, 2039 (in
the case of the 2040 Notes) and November 1, 2049 (in the case of the
2050 Notes), at a redemption price equal to 100% of the principal amount
of such notes to be redeemed, plus accrued and unpaid interest, if any, to,
but excluding, the redemption date.
Use of proceeds
We estimate that the net proceeds from the sale of the notes will be
approximately $5.94 billion after deducting the underwriting discount and
our estimated expenses of this offering. Concurrently with this offering, we
commenced the GE Tender Offers. See "Recent Developments--Tender
Offers." We intend to use the net proceeds from the sale of the notes to
fund the tender offer for General Electric's 2.700% Notes due 2022, of
which $3.0 billion principal amount is outstanding; 0.375% Notes due
2022, of which approximately 1.8 billion principal amount is outstanding;
1.250% Notes due 2023, of which approximately 1.2 billion principal
amount is outstanding; 3.375% Notes due 2024, of which $750 million
principal amount is outstanding; and Floating Rate
S-7

Notes due 2020, of which 650 million principal amount is outstanding.
To the extent any net proceeds exceed the amount used to repurchase the
notes subject to the tender, we intend to use such remaining proceeds to
repurchase, redeem or repay General Electric's outstanding debt
obligations, including other notes or commercial paper.
Ranking
The notes will be unsecured obligations of ours and will rank equally with
our other unsecured and unsubordinated indebtedness.
Denominations
The notes will be issued in denominations of $2,000 and integral multiples
of $1,000 in excess thereof.
https://www.sec.gov/Archives/edgar/data/40545/000093041320001094/c95731_424b2.htm[4/15/2020 8:30:02 AM]

3B2 EDGAR HTML -- c95731_preflight.htm
Form of Notes
The notes will be issued only in fully registered, book-entry form. One or
more global notes will be deposited with or on behalf of The Depository
Trust Company ("DTC").
Absence of Public Market
The notes are new securities for which there is currently no established
market. Accordingly, we cannot assure you as to the development or
liquidity of any market for the notes. We have been advised by the
underwriters that they presently intend to make a market in the notes after
completion of the offering. However, they are under no obligation to do so
and may discontinue any market-making activities at any time without any
notice.
Additional Issues
We may from time to time, without notice to or the consent of the holders
of any series of notes, create and issue additional notes of such series
ranking equally and ratably with such series of notes in all respects, or in
all respects except for the payment of interest accruing prior to the issue
date or except for the first payment of interest following the issue date of
those additional notes; provided that, if such additional notes are not
fungible for U.S. federal income tax purposes with the notes of the
applicable series, such additional notes will have a different CUSIP. Any
such additional notes will have the same terms as to status, redemption or
otherwise as the applicable series of notes.
Governing Law
The notes and the indenture under which they will be issued will be
governed by New York law.
Listing
The notes will not be listed on any securities exchange.
Trustee, Registrar and Paying Agent
The Bank of New York Mellon.
Risk Factors
Investing in the notes involves risks. See "Risk Factors" for more
information.
S-8

RISK FACTORS
Investing in the notes involves risks. You should carefully consider the risks described under "Risk Factors" in Item 1A of our
Annual Report on Form 10-K for the year ended December 31, 2019 (which Risk Factors are incorporated by reference herein), as
such descriptions may be updated or amended in any future reports we file with the SEC, as well as the other information contained
or incorporated by reference in this prospectus supplement and the accompanying prospectus before making a decision to invest in our
notes. See "Where You Can Find More Information" above.
The global COVID-19 pandemic is having a material adverse impact on our operations and financial performance, as well as
on the operations and financial performance of many of the customers and suppliers in industries that we serve. We are unable to
predict the extent to which the pandemic and related impacts will continue to adversely impact our business operations, financial
performance, results of operations, financial position and the achievement of our strategic objectives.
Our operations and financial performance have been negatively impacted by the COVID-19 pandemic that has caused, and is
expected to continue to cause, the global slowdown of economic activity (including the decrease in demand for a broad variety of
goods and services), disruptions in global supply chains and significant volatility and disruption of financial markets. Because the
severity, magnitude and duration of the COVID-19 pandemic and its economic consequences are uncertain, rapidly changing and
difficult to predict, the pandemic's impact on our operations and financial performance, as well as its impact on our ability to
successfully execute our business strategies and initiatives, remains uncertain and difficult to predict. Further, the ultimate impact of
the COVID-19 pandemic on our operations and financial performance depends on many factors that are not within our control,
including, but not limited, to: governmental, business and individuals' actions that have been and continue to be taken in response to
the pandemic (including restrictions on travel and transport and workforce pressures); the impact of the pandemic and actions taken in
response on global and regional economies, travel, and economic activity; the availability of federal, state, local or non-U.S. funding
programs; general economic uncertainty in key global markets and financial market volatility; global economic conditions and levels
of economic growth; and the pace of recovery when the COVID-19 pandemic subsides.
The COVID-19 pandemic has subjected our operations, financial performance and financial condition to a number of risks,
including, but not limited to those discussed below:
https://www.sec.gov/Archives/edgar/data/40545/000093041320001094/c95731_424b2.htm[4/15/2020 8:30:02 AM]

3B2 EDGAR HTML -- c95731_preflight.htm

· Operations-related risks: Across all of our businesses, we are facing increased operational challenges from the need to protect
employee health and safety, site shutdowns, workplace disruptions and restrictions on the movement of people, raw materials
and goods, both at our own facilities and at customers and suppliers. We are also experiencing, and expect to continue
experiencing, lower demand and volume for products and services, customer requests for potential payment deferrals or other
contract modifications, supply chain under-liquidation, delays of deliveries and the achievement of other billing milestones and
other factors related directly and indirectly to the COVID-19 pandemic that adversely impact our businesses. We expect that
the longer the period of economic and global supply chain and disruption continues, the more material the adverse impact will
be on our business operations, financial performance and results of operations.

· Customer-related risks: In particular, the interruption of regional and international air travel from COVID-19 has resulted in
the loss of business and leisure traffic and is having a material adverse effect on our airline and airframer customers, the
viability of their businesses and their demand for our services and products. Changes in passenger air travel trends arising from
COVID-19 may continue to develop or persist over time and further contribute to this adverse effect. We are also observing a
significant increase in the number of requests for payment deferrals, contract modifications, aircraft lease restructurings and
similar actions across the aviation sector, and these trends may lead to additional charges, impairments and other adverse
financial impacts at GE Aviation and GE Capital Aviation Services over time. We have depended on the strength of our
Aviation business as we have been working to
S-9

improve the operations and execution of other GE businesses and strengthen the company's balance sheet. As a result,
disruption of the aviation industry, which could continue for an uncertain period of time, is particularly significant for GE.

· Leverage- and market-related risks: The current financial market dynamics and volatility pose heightened risks to our
previously announced timelines for decreasing our leverage, which we expect to be delayed as we seek to maintain appropriate
liquidity to compensate for lower cash flows from operations or as variables impacting our leverage ratios fluctuate with
extreme market volatility. For example, dramatically lowered interest rates and lower expected asset valuations and returns can
materially impact the calculation of long-term liabilities such as our pension, GAAP insurance reserve and insurance statutory
calculations. In addition, extreme volatility in financial and commodities markets has had and may continue to have adverse
impacts on other asset valuations such as the market value of our remaining equity interest in Baker Hughes and the value of
the investment portfolios supporting our pension and long-term insurance liabilities. Our long-term liabilities are sensitive to
numerous factors and assumptions that can move in offsetting directions and should be considered as of the time of a relevant
measurement event.

· Liquidity- and funding-related risks: While we have significant sources of cash and liquidity and access to committed credit
lines, a prolonged period of generating lower cash from operations could adversely affect our financial condition and the
achievement of our strategic objectives. Additionally, there can also be no assurance that we will not face additional credit
rating downgrades as a result of weaker than anticipated performance of our businesses, slower progress in decreasing our
leverage or other factors. Future downgrades could further adversely affect our cost of funds and related margins, liquidity,
competitive position and access to capital markets, and a significant downgrade could have an adverse commercial impact on
our industrial businesses. Conditions in the financial and credit markets may also limit the availability of funding or increase
the cost of funding (including for receivables monetization or supply chain finance programs), which could adversely affect our
business, financial position and results of operations. Although the U.S. federal and other governments have announced a
number of funding programs to support businesses, our ability or willingness to access funding under such programs may be
limited by regulations or other guidance, or by further change or uncertainty related to the terms of these programs.
As the COVID-19 pandemic continues to adversely affect our operating and financial results, it may also have the effect of
heightening many of the other risks described in the risk factors in our Annual Report on Form 10-K for the year ended December
31, 2019. In particular, see the risk factors regarding "Global macro-environment," "Supply chain," "Leverage and borrowings,"
"Liquidity" and "Economy, customers & counterparties." Refer also to the discount rate and other sensitivities included for our
pension benefit obligations in "Critical Accounting Estimates" and for our run-off insurance operations in "Other Items" in our
Annual Report on Form 10-K for the year ended December 31, 2019. Further, the COVID-19 pandemic may also affect our operating
and financial results in a manner that is not presently known to us or that we currently do not expect to present significant risks to our
operations or financial results.
S-10
https://www.sec.gov/Archives/edgar/data/40545/000093041320001094/c95731_424b2.htm[4/15/2020 8:30:02 AM]

Document Outline

#1">
- #1">